Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.

Rubin MR, Cusano NE, Fan WW, Delgado Y, Zhang C, Costa AG, Cremers S, Dworakowski E, Bilezikian JP.

J Clin Endocrinol Metab. 2016 Jul;101(7):2742-50. doi: 10.1210/jc.2015-4135. Epub 2016 May 4.

2.

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.

Furst JR, Bandeira LC, Fan WW, Agarwal S, Nishiyama KK, McMahon DJ, Dworakowski E, Jiang H, Silverberg SJ, Rubin MR.

J Clin Endocrinol Metab. 2016 Jun;101(6):2502-10. doi: 10.1210/jc.2016-1437. Epub 2016 Apr 26.

3.

Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus.

Rubin MR, Goldfine AB, McMahon DJ, Donovan DS, Cremers S, Dworakowski E, Schaefer EJ, Shoelson SE, Silverberg SJ.

Endocrine. 2015 Nov;50(2):504-7. doi: 10.1007/s12020-015-0535-8. Epub 2015 Feb 1. No abstract available.

4.

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2015 Feb;26(2):187-203. doi: 10.1007/s10552-014-0497-9. Epub 2014 Nov 25.

5.

Comparison of two commercially available ELISAs for circulating sclerostin.

Costa AG, Cremers S, Dworakowski E, Lazaretti-Castro M, Bilezikian JP.

Osteoporos Int. 2014 May;25(5):1547-54. doi: 10.1007/s00198-014-2635-3. Epub 2014 Feb 22.

PMID:
24562839
6.

Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton.

Iyer SP, Nikkel LE, Nishiyama KK, Dworakowski E, Cremers S, Zhang C, McMahon DJ, Boutroy S, Liu XS, Ratner LE, Cohen DJ, Guo XE, Shane E, Nickolas TL.

J Am Soc Nephrol. 2014 Jun;25(6):1331-41. doi: 10.1681/ASN.2013080851. Epub 2014 Feb 7.

7.

Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.

Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, Liu G, Bilezikian JP.

J Clin Endocrinol Metab. 2013 Dec;98(12):4736-43. doi: 10.1210/jc.2013-2106. Epub 2013 Sep 13.

8.

Rapid cortical bone loss in patients with chronic kidney disease.

Nickolas TL, Stein EM, Dworakowski E, Nishiyama KK, Komandah-Kosseh M, Zhang CA, McMahon DJ, Liu XS, Boutroy S, Cremers S, Shane E.

J Bone Miner Res. 2013 Aug;28(8):1811-20. doi: 10.1002/jbmr.1916.

9.

Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Stein EM, Silva BC, Boutroy S, Zhou B, Wang J, Udesky J, Zhang C, McMahon DJ, Romano M, Dworakowski E, Costa AG, Cusano N, Irani D, Cremers S, Shane E, Guo XE, Bilezikian JP.

J Bone Miner Res. 2013 May;28(5):1029-40. doi: 10.1002/jbmr.1841.

10.

Circulating osteogenic precursor cells in type 2 diabetes mellitus.

Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S, Rubin MR.

J Clin Endocrinol Metab. 2012 Sep;97(9):3240-50. doi: 10.1210/jc.2012-1546. Epub 2012 Jun 27.

11.

Discriminants of prevalent fractures in chronic kidney disease.

Nickolas TL, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin MT, Liu XS, Boutroy S, Staron RB, Leonard MB, McMahon DJ, Dworakowski E, Shane E.

J Am Soc Nephrol. 2011 Aug;22(8):1560-72. doi: 10.1681/ASN.2010121275. Epub 2011 Jul 22.

12.

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Rubin MR, Dempster DW, Sliney J Jr, Zhou H, Nickolas TL, Stein EM, Dworakowski E, Dellabadia M, Ives R, McMahon DJ, Zhang C, Silverberg SJ, Shane E, Cremers S, Bilezikian JP.

J Bone Miner Res. 2011 Nov;26(11):2727-36. doi: 10.1002/jbmr.452.

13.

Bone structure and turnover in type 2 diabetes mellitus.

Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR.

Osteoporos Int. 2012 Feb;23(2):635-41. doi: 10.1007/s00198-011-1595-0. Epub 2011 Mar 19.

14.

Association between plasma 25-hydroxyvitamin D and breast cancer risk.

Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM.

Cancer Prev Res (Phila). 2009 Jun;2(6):598-604. doi: 10.1158/1940-6207.CAPR-08-0138. Epub 2009 May 26.

15.

Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration.

Ogita M, Rached MT, Dworakowski E, Bilezikian JP, Kousteni S.

Endocrinology. 2008 Nov;149(11):5713-23. doi: 10.1210/en.2008-0369. Epub 2008 Jul 10.

Supplemental Content

Loading ...
Support Center